Funds holding Immunome Inc
ISIN US45257U1088 · United States
- Fund holders
- 211
- Of which ETFs
- 41 170 other funds
- Value held
- 1.1B $
- Share of capital
- 45.3 % of 113.6M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 5,764,704 | 126.1M $ | 1.56 % | 5.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 4,507,411 | 98.5M $ | 0.12 % | 3.97 % | as of Feb 28, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 3,867,541 | 88.7M $ | 1.31 % | 3.41 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,166,083 | 69.2M $ | 0.00 % | 2.79 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 3,117,210 | 68.2M $ | 1.57 % | 2.74 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 2,934,802 | 64.2M $ | 0.86 % | 2.58 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 2,776,580 | 63.7M $ | 0.17 % | 2.44 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 2,489,937 | 54.5M $ | 0.08 % | 2.19 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 2,131,664 | 46.6M $ | 0.87 % | 1.88 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,665,614 | 36.4M $ | 0.33 % | 1.47 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 1,617,893 | 35.4M $ | 0.38 % | 1.42 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 1,315,710 | 28.8M $ | 0.12 % | 1.16 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,224,497 | 26.8M $ | 0.13 % | 1.08 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,156,375 | 25.3M $ | 0.03 % | 1.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1,010,028 | 23.2M $ | 0.07 % | 0.89 % | as of Apr 30, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 834,227 | 18.2M $ | 0.15 % | 0.73 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 814,396 | 17.8M $ | 0.82 % | 0.72 % | as of Mar 31, 2026 ↗ |
| SmallCap Fund Principal Funds, Inc | 550,700 | 12.6M $ | 0.60 % | 0.48 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 541,392 | 11.8M $ | 0.03 % | 0.48 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 504,200 | 11M $ | 0.05 % | 0.44 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 464,133 | 10.1M $ | 0.07 % | 0.41 % | as of Feb 28, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 403,825 | 8.8M $ | 0.01 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 368,708 | 8.1M $ | 0.16 % | 0.32 % | as of Mar 31, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 346,498 | 7.6M $ | 0.66 % | 0.31 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 288,792 | 6.3M $ | 0.10 % | 0.25 % | as of Feb 27, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 281,599 | 6.2M $ | 0.03 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 275,871 | 6M $ | 1.32 % | 0.24 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 262,917 | 5.7M $ | 0.40 % | 0.23 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 257,378 | 5.6M $ | 0.46 % | 0.23 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 229,760 | 5M $ | 0.06 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 224,186 | 5.1M $ | 0.07 % | 0.20 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 195,451 | 4.3M $ | 2.67 % | 0.17 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 192,296 | 4.2M $ | 0.00 % | 0.17 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 191,441 | 4.2M $ | 0.10 % | 0.17 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 168,145 | 3.9M $ | 0.74 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 165,908 | 3.6M $ | 0.08 % | 0.15 % | as of Mar 31, 2026 ↗ |
| First Trust Small Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 157,162 | 3.6M $ | 0.34 % | 0.14 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 154,249 | 3.4M $ | 0.00 % | 0.14 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 140,728 | 3.1M $ | 0.00 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Adara Smaller Companies Fund RBB Fund, Inc. | 132,949 | 2.9M $ | 0.38 % | 0.12 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 128,082 | 2.8M $ | 0.02 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 122,169 | 2.8M $ | 0.07 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 120,942 | 2.6M $ | 0.22 % | 0.11 % | as of Feb 28, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 117,155 | 2.7M $ | 0.37 % | 0.10 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 107,386 | 2.3M $ | 0.35 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Victory Small Cap Stock Fund Victory Portfolios III | 107,073 | 2.5M $ | 0.27 % | 0.09 % | as of Apr 30, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 106,411 | 2.3M $ | 0.07 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Column Small Cap Select Fund Trust for Professional Managers | 101,877 | 2.2M $ | 0.13 % | 0.09 % | as of Feb 28, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 97,109 | 2.1M $ | 0.11 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 94,842 | 2.1M $ | 0.36 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 91,124 | 2.1M $ | 0.00 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Optimum Small-Mid Cap Growth Fund Optimum Fund Trust | 87,978 | 1.9M $ | 0.25 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 87,699 | 1.9M $ | 0.01 % | 0.08 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 85,840 | 1.9M $ | 0.13 % | 0.08 % | as of Feb 28, 2026 ↗ |
| JNL Multi-Manager Small Cap Growth Fund JNL Series Trust | 83,440 | 1.8M $ | 0.09 % | 0.07 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 80,028 | 1.8M $ | 0.00 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 77,611 | 1.7M $ | 0.15 % | 0.07 % | as of Mar 31, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 74,700 | 1.6M $ | 0.01 % | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Spectrum Moderate Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 70,487 | 1.5M $ | 0.07 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 69,030 | 1.5M $ | 0.11 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 66,400 | 1.5M $ | 0.01 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 64,856 | 1.4M $ | 0.37 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 63,682 | 1.4M $ | 0.01 % | 0.06 % | as of Feb 28, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 63,500 | 1.4M $ | 0.07 % | 0.06 % | as of Mar 31, 2026 ↗ |
| First Trust Small Cap Core AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 63,318 | 1.5M $ | 0.12 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 62,658 | 1.4M $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 61,976 | 1.4M $ | 0.06 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 60,200 | 1.3M $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 57,119 | 1.2M $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 54,321 | 1.2M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Aristotle Core Equity Fund Aristotle Fund Series Trust | 54,292 | 1.2M $ | 0.23 % | 0.05 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 52,038 | 1.2M $ | 0.65 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 51,154 | 1.1M $ | 0.15 % | 0.05 % | as of Feb 28, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 51,070 | 1.1M $ | 0.07 % | 0.04 % | as of Mar 31, 2026 ↗ |
| SMALL CAP EQUITY FUND GuideStone Funds | 50,714 | 1.1M $ | 0.13 % | 0.04 % | as of Mar 31, 2026 ↗ |
| SmallCap Account Principal Variable Contract Funds, Inc | 49,500 | 1.1M $ | 0.64 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 47,957 | 1M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 47,294 | 1M $ | 0.07 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 46,826 | 1M $ | 0.02 % | 0.04 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Spectrum Conservative Allocation Fund T. ROWE PRICE SPECTRUM FUNDS II, INC. | 46,084 | 1M $ | 0.05 % | 0.04 % | as of Feb 28, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 45,266 | 990K $ | 0.11 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 44,221 | 1M $ | 0.07 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 42,979 | 985.9K $ | 0.03 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 39,589 | 865.8K $ | 0.38 % | 0.03 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 38,437 | 840.2K $ | 0.02 % | 0.03 % | as of Feb 27, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 38,028 | 831.3K $ | 0.07 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 36,342 | 833.7K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 35,813 | 783.2K $ | 0.09 % | 0.03 % | as of Mar 31, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 35,600 | 778.6K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 34,800 | 761.1K $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 33,871 | 777K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 33,396 | 766.1K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 32,460 | 709.9K $ | 0.04 % | 0.03 % | as of Mar 31, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 32,418 | 709K $ | 0.07 % | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 30,966 | 677.2K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 30,416 | 665.2K $ | 0.06 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 30,317 | 662.7K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 29,606 | 647.5K $ | 0.07 % | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap Growth ETF iShares Trust | 29,061 | 666.7K $ | 0.07 % | 0.03 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 27,593 | 603.5K $ | 0.09 % | 0.02 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Tema Oncology ETF Tema ETF Trust | 2.67 % | as of Feb 28, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 1.86 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 1.57 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 1.56 % | as of Mar 31, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 1.32 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 1.31 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1.15 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.87 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.87 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.86 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 211 | +23 | 51,419,517 | +13.1 % |
| 2026Q1 | 188 | +38 | 45,446,913 | +51.7 % |
| 2025Q4 | 150 | +1 | 29,955,188 | +13.0 % |
| 2025Q3 | 149 | +10 | 26,504,246 | +2.5 % |
| 2025Q2 | 139 | +4 | 25,849,469 | +21.7 % |
| 2025Q1 | 135 | +9 | 21,247,875 | +15.1 % |
| 2024Q4 | 126 | +43 | 18,465,255 | +24.3 % |
| 2024Q3 | 83 | +22 | 14,855,379 | +47.1 % |
| 2024Q2 | 61 | +40 | 10,101,459 | +267.2 % |
| 2024Q1 | 21 | 0 | 2,750,605 | +379.0 % |
| 2023Q4 | 21 | 574,237 |
Institutional managers
191 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 16,969,954 | 371.1M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 16,364,011 | 357.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 8,168,674 | 178.6M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 5,558,885 | 121.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,399,901 | 118.1M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 4,788,231 | 104.7M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 4,731,977 | 103.5M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 4,099,901 | 89.7M $ | as of Mar 31, 2026 |
| ENAVATE SCIENCES GP, LLC | 3,613,799 | 79M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,858,863 | 62.5K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,841,589 | 62.1M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,777,836 | 53.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,560,664 | 56M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,850,278 | 40.5M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 1,701,904 | 37.2M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 1,575,398 | 34.5M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,480,788 | 32.4M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 1,376,867 | 30.1M $ | as of Mar 31, 2026 |
| READYSTATE ASSET MANAGEMENT LP | 1,301,862 | 28.5M $ | as of Mar 31, 2026 |
| Jefferies Financial Group Inc. | 1,160,715 | 25.4M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,101,476 | 24.1M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,097,836 | 24M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 899,146 | 19.7M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 851,789 | 18.6M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 849,479 | 18.6M $ | as of Mar 31, 2026 |
Declared shareholders of Immunome Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14.50 % | 16,364,011 | as of Mar 31, 2026 · SCHEDULE 13G |
| Sirenia Capital Management LP and 1 other | 6.10 % | 6,895,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Redmile Group, LLC and 1 other | 4.90 % | 5,558,885 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Immunome Inc". https://titelia.com/en/stocks/immunome-inc-US45257U1088